160 related articles for article (PubMed ID: 29895160)
1. Antiviral effect of a derivative of isonicotinic acid enisamium iodide (FAV00A) against influenza virus.
Cocking D; Cinatl J; Boltz DA; Peng X; Johnson W; Muzzio M; Syarkevych O; Kostyuk G; Goy A; Mueller L; Margitich VI
Acta Virol; 2018; 62(2):191-195. PubMed ID: 29895160
[TBL] [Abstract][Full Text] [Related]
2. Activity of enisamium, an isonicotinic acid derivative, against influenza viruses in differentiated normal human bronchial epithelial cells.
Boltz D; Peng X; Muzzio M; Dash P; Thomas PG; Margitich V
Antivir Chem Chemother; 2018; 26():2040206618811416. PubMed ID: 30466301
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
[TBL] [Abstract][Full Text] [Related]
4. Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway.
Yan H; Wang H; Ma L; Ma X; Yin J; Wu S; Huang H; Li Y
Virol J; 2018 May; 15(1):88. PubMed ID: 29783993
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of phenanthrenes from the medicinal plant Bletilla striata against influenza A virus.
Shi Y; Zhang B; Lu Y; Qian C; Feng Y; Fang L; Ding Z; Cheng D
BMC Complement Altern Med; 2017 May; 17(1):273. PubMed ID: 28532402
[TBL] [Abstract][Full Text] [Related]
6. Impact of a large deletion in the neuraminidase protein identified in a laninamivir-selected influenza A/Brisbane/10/2007 (H3N2) variant on viral fitness in vitro and in ferrets.
Ann J; Abed Y; Beaulieu E; Bouhy X; Joly MH; Dubé K; Carbonneau J; Hamelin ME; Mallett C; Boivin G
Influenza Other Respir Viruses; 2016 Mar; 10(2):122-6. PubMed ID: 26526406
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.
Ding Y; Dou J; Teng Z; Yu J; Wang T; Lu N; Wang H; Zhou C
Arch Virol; 2014 Dec; 159(12):3269-78. PubMed ID: 25078390
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of EdAP, a 4'-Ethynyl-2'-Deoxyadenosine 5'-Monophosphate Analog, as a Potent Influenza a Inhibitor.
Takeuchi T; Sriwilaijaroen N; Sakuraba A; Hayashi E; Kamisuki S; Suzuki Y; Ohrui H; Sugawara F
Molecules; 2019 Jul; 24(14):. PubMed ID: 31319565
[TBL] [Abstract][Full Text] [Related]
10. Antiviral Activity of 3D, a Butene Lactone Derivative Against Influenza A Virus In Vitro and In Vivo.
Wang Z; Fang J; Luo J; Hou D; Tan Y; Gu Z; Ge Y; Mao L; Liu L; Liu H; Wei Z; Xu H
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670217
[TBL] [Abstract][Full Text] [Related]
11. Enisamium Reduces Influenza Virus Shedding and Improves Patient Recovery by Inhibiting Viral RNA Polymerase Activity.
Te Velthuis AJW; Zubkova TG; Shaw M; Mehle A; Boltz D; Gmeinwieser N; Stammer H; Milde J; Müller L; Margitich V
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558285
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system.
Patel U; Gingerich A; Widman L; Sarr D; Tripp RA; Rada B
PLoS One; 2018; 13(7):e0199167. PubMed ID: 30044776
[TBL] [Abstract][Full Text] [Related]
13. Polyunsaturated fatty acids from Phyllocaulis boraceiensis mucus block the replication of influenza virus.
de Toledo-Piza AR; de Oliveira MI; Negri G; Mendonça RZ; Figueiredo CA
Arch Microbiol; 2018 Aug; 200(6):961-970. PubMed ID: 29616305
[TBL] [Abstract][Full Text] [Related]
14. Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.
Gao L; Han J; Si J; Wang J; Wang H; Sun Y; Bi Y; Liu J; Cao L
Antiviral Res; 2017 Jul; 143():106-112. PubMed ID: 28232246
[TBL] [Abstract][Full Text] [Related]
15. In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.
Ikematsu H; Kawai N; Iwaki N; Kashiwagi S
J Infect Chemother; 2014 Feb; 20(2):77-80. PubMed ID: 24560563
[TBL] [Abstract][Full Text] [Related]
16. Anti-influenza virus activity of a salcomine derivative mediated by inhibition of viral RNA synthesis.
Takizawa N; Kimura T; Watanabe T; Shibasaki M
Arch Virol; 2018 Jun; 163(6):1607-1614. PubMed ID: 29497849
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of 2,4-dichlorophenoxyacetic acid on ROS, autophagy formation, and mRNA replication for influenza virus infection.
Enkhtaivan G; Muthuraman P; Kim DH
J Mol Recognit; 2017 Aug; 30(8):. PubMed ID: 28233349
[TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses.
Courtin N; Fotso AF; Fautrad P; Mas F; Alessi MC; Riteau B
Antiviral Res; 2017 Jul; 143():252-261. PubMed ID: 28483551
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of synergistic inhibitory effects of neuraminidase inhibitors and methylglyoxal against influenza virus infection.
Charyasriwong S; Watanabe K; Rahmasari R; Matsunaga A; Haruyama T; Kobayashi N
Arch Med Res; 2015 Jan; 46(1):8-16. PubMed ID: 25523147
[TBL] [Abstract][Full Text] [Related]
20. Antiviral resistance in influenza viruses--implications for management and pandemic response.
Hayden FG
N Engl J Med; 2006 Feb; 354(8):785-8. PubMed ID: 16495389
[No Abstract] [Full Text] [Related]
[Next] [New Search]
